Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-08 Wallace Owen B. Chief Scientific Officer Sale −2,951 $20.00 $59K 127,088
2020-07-08 Wallace Owen B. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −2,951 81,942
2020-07-08 Gould Robert J Sale −2,500 $20.00 $50K 534,845
2020-07-01 Cadavid Diego SVP Clinical Development Sale −1,071 $18.30 $20K 65,714
2020-06-30 Wallace Owen B. Chief Scientific Officer Exercise or conversion +141 $7.84 $1K 127,229
2020-06-30 Wallace Owen B. Chief Scientific Officer Sale −141 $20.00 $3K 127,088
2020-06-30 Wallace Owen B. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −141 84,893
2020-06-25 Cadavid Diego SVP Clinical Development Exercise or conversion +1,459 $4.83 $7K 68,244
2020-06-25 Cadavid Diego SVP Clinical Development Sale −1,459 $22.00 $32K 66,785
2020-06-25 Cadavid Diego SVP Clinical Development Exercise or conversion · Stock Option (right to buy) −1,459 12,277
2020-06-25 Gould Robert J Sale −2,500 $20.80 $52K 537,345
2020-06-11 LEVIN MARK J Director Grant or award · Stock Option (right to buy) +9,285 9,285
2020-06-11 GERAGHTY JAMES A Director Grant or award · Stock Option (right to buy) +9,285 9,285
2020-06-11 Ezekowitz Alan Director Grant or award · Stock Option (right to buy) +9,285 9,285
2020-06-11 Collins James J. Director Grant or award · Stock Option (right to buy) +9,285 9,285
2020-06-11 Haviland Kate Director Grant or award · Stock Option (right to buy) +9,285 9,285
2020-06-10 Cadavid Diego SVP Clinical Development Exercise or conversion +401 $4.83 $2K 67,186
2020-06-10 Cadavid Diego SVP Clinical Development Sale −401 $22.00 $9K 66,785
2020-06-10 Cadavid Diego SVP Clinical Development Exercise or conversion · Stock Option (right to buy) −401 13,736
2020-06-09 Gould Robert J Sale −156 $20.00 $3K 539,845

Page 10 of 15 · 291 trades